PAD4 and Its Inhibitors in Cancer Progression and Prognosis

The systemic spread of malignancies and the risk of cancer-associated thrombosis are major clinical challenges in cancer therapy worldwide. As an important post-translational modification enzyme, peptidyl arginine deiminase 4 (PAD4) could mediate the citrullination of protein in different components...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Di, Lu, Yu, Wang, Yanming, Wang, Yuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699117/
https://www.ncbi.nlm.nih.gov/pubmed/36365233
http://dx.doi.org/10.3390/pharmaceutics14112414

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699117/
https://www.ncbi.nlm.nih.gov/pubmed/36365233
http://dx.doi.org/10.3390/pharmaceutics14112414

Ejemplares similares